New tool helps people living with type 2 diabetes stick to prescribed medications
Published on 11 October 2022
This final phase used the questions to evaluate the effectiveness of the SPUR tool at measuring medication adherence in 378 patients living with type 2 diabetes, recruited through Kingston Hospital and community pharmacies in South West London with the support of the National Pharmacy Association and the Health Education Foundation.
Researchers believed that as people around the globe face further hardship as part of the cost-of-living crisis, having access to tools such as SPUR to support patients was more important than ever.
Mr Wells said. “Patients with specific vulnerabilities, particularly those who experience social deprivation, are more exposed and at risk of chronic illness and that only worsens with age. We’re seeing an ageing population that requires a greater range and complexity of medicines to manage multiple chronic illnesses and the increasing costs to healthcare systems will only continue to exacerbate health inequalities in the UK and the challenge for these patients to manage their growing list of medicines.”
Kingston University and Observia are working closely to develop further relationships within the NHS to support the integration of the SPUR model more broadly, in a bid to improve the day-to-day care for patients who take medication for chronic illnesses, and are also continuing to validate the model in other languages, patient populations and conditions other than type 2 diabetes.
Read the report in British Medical Journal Open
Find out more about type 2 diabetes
Support DRWF by making a donation here
Find out more about DRWF-funded research here
Find out more about DRWF fundraising here
To receive the charity’s latest bulletins as they become available, please sign up here
Read DRWF diabetes information leaflets here
Join the Diabetes Wellness Network here
I would like to make a regular donation of
I would like to make a single donation of